Clinical Trials Logo

Citation(s)

Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia

Details for clinical trial NCT01429610